Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of AGRIPPAL S1 influenza vaccine 2005-2006 formulation in non-elderly and elderly adults
2005-000622-23Phase 2Completed
- Sponsor
- Chiron Corporation
- Start
- Aug 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of influenza vaccine, inactivated, surface antigen in influenza, sponsored by Chiron Corporation. Primary endpoint: Compliance with CPMP criteria for influenza vaccines. Started Aug 2007; status: completed.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-000622-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000622-23.